Opus Genetics, Inc.(IRD) - 2024 Q4 - Annual Results

Opus Genetics, Inc.(US:IRD)2025-03-31 12:26

Financial Performance - The company reported a net loss of approximately $56.8 million for the year ended December 31, 2024[6] - Net cash used in operating activities for the year ended December 31, 2024 was approximately $25.6 million[6] Cash Position - The cash and cash equivalents balance as of December 31, 2024 was approximately $30.3 million[6]